BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 29209796)

  • 1. The Role of MDM2 Amplification and Overexpression in Tumorigenesis.
    Oliner JD; Saiki AY; Caenepeel S
    Cold Spring Harb Perspect Med; 2016 Jun; 6(6):. PubMed ID: 27194168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MDM2 gene amplification database.
    Momand J; Jung D; Wilczynski S; Niland J
    Nucleic Acids Res; 1998 Aug; 26(15):3453-9. PubMed ID: 9671804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spindle-cell osteosclerotic bone lesion with MDM2 amplification].
    Mogler C; Boxberg M; Knebel C; Weichert W; Wörtler K; Specht K
    Pathologe; 2018 Mar; 39(2):186-190. PubMed ID: 29209796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
    Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
    Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MDM2 SNP309 G allele is not preferentially amplified in bone and soft tissue tumors.
    Mertens F; Brosjö O; von Steyern FV; Nord KH; Mandahl N
    Cancer Genet; 2012 Sep; 205(9):470-3. PubMed ID: 22939400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.
    Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS
    Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 and CDK4 gene amplification in Ewing's sarcoma.
    Ladanyi M; Lewis R; Jhanwar SC; Gerald W; Huvos AG; Healey JH
    J Pathol; 1995 Feb; 175(2):211-7. PubMed ID: 7738717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
    Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
    Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.
    Schrock AB; Frampton GM; Suh J; Chalmers ZR; Rosenzweig M; Erlich RL; Halmos B; Goldman J; Forde P; Leuenberger K; Peled N; Kalemkerian GP; Ross JS; Stephens PJ; Miller VA; Ali SM; Ou SH
    J Thorac Oncol; 2016 Sep; 11(9):1493-502. PubMed ID: 27343443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression and relationship with MDM2 amplification in breast carcinomas.
    Buyukpinarbasili N; Gucin Z; Ersoy YE; İlbak A; Kadioglu H; Muslumanoglu M
    Ann Diagn Pathol; 2016 Apr; 21():29-34. PubMed ID: 27040927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parosteal osteosarcoma.
    Hang JF; Chen PC
    Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases.
    Hayashi K; Tsuchiya H; Yamamoto N; Shirai T; Nishida H; Takeuchi A; Kimura H; Miwa S; Inatani H; Okamoto H; Yamada S; Ikeda H; Sawada-Kitamura S; Nojima T; Ooi A; Otsuka T
    Int J Clin Oncol; 2014 Aug; 19(4):731-8. PubMed ID: 23881556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer pathology and underlying molecular mechanisms.
    Grabsch HI; Tan P
    Dig Surg; 2013; 30(2):150-8. PubMed ID: 23867592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade central osteosarcoma arising from bone infarct.
    Endo M; Yoshida T; Yamamoto H; Ishii T; Setsu N; Kohashi K; Matsunobu T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Jun; 44(6):1184-9. PubMed ID: 23375641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes.
    Duhamel LA; Ye H; Halai D; Idowu BD; Presneau N; Tirabosco R; Flanagan AM
    Histopathology; 2012 Jan; 60(2):357-9. PubMed ID: 22074548
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.